
Nirwana Health Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.2/10
Best for: oral or injectable compounded GLP-1 with cheaper multi-month plans
Price is where Nirwana Health scores best in our breakdown.
Semaglutide
Tirzepatide
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Not disclosed
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
Nirwana Health (nirwanahealth.com) is a telehealth service offering compounded GLP-1 weight loss plus hair, sexual-wellness, and longevity care through licensed providers. It offers compounded semaglutide and tirzepatide as weekly injections and as oral tablets, with month-to-month, quarterly, and 6-month plans and no membership fee. Semaglutide injection runs $149/mo month-to-month (as low as $99/mo on a 6-month plan) and tirzepatide $229/mo; oral versions are $199 and $249/mo. It advertises a $50-off code, though the prescribing entity, pharmacy, and states are not published.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to Nirwana Health
Sprout Health
Best for: LegitScript-certified compounded GLP-1 via named pharmacies
Editorial score · methodology
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
MEDVi
Best for: switching between compounded and brand-name GLP-1 through one provider
Editorial score · methodology
Nirwana Health at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $149/mo
- Pricing model
- Flat — dose increases don't raise the monthly price
- What's included
- Medication · Consult
- FDA status
- No FDA warning letter on record
How we scored Nirwana Health
Each dimension is scored algorithmically from Nirwana Health’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
8.1/10At $149/mo, Nirwana Health runs about 17% below the $179 median for GLP-1 providers (each one's cheapest ongoing monthly price). Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
7.8/10Nirwana Health offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes. An oral/needle-free option is offered for patients who avoid injections.
User Experience15%
7.0/10Online intake and platform experience — consult included in the price; 8 platform features disclosed.
Trust & Safety15%
6.9/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
5.7/10Nirwana Health's exact state footprint isn't published — confirm coverage in your state before signing up.
Support10%
5.5/10Nirwana Health provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Nirwana Health review
Last checked August 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $149–$199/mo across 2 dose/plan tiers — checked August 2026
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with Nirwana Health
We walked Nirwana Health’s public signup flow in July 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Pick a treatment (e.g. semaglutide or tirzepatide) and see published plan prices up front.
- 2Choose a plan term: 1-month one-time, monthly, 3-month, or 6-month subscription.
- 3Complete an online consultation reviewed by a licensed provider.
- 4If approved, your medication ships to your door; a $50-off code (LOOSE50) is advertised.
- Pricing is public before signup, shown as plan cards by term with a clear per-month rate.
- Both weekly injections and oral tablets are offered for semaglutide and tirzepatide.
- Longer plans lower the per-month cost (semaglutide to $99/mo, tirzepatide to $133/mo on 6 months).
- No membership fee; the site also offers a retatrutide option and custom dosing plans.
- The site claims LegitScript certification, but no verifiable seal is displayed.
GLP-1 medications Nirwana Health offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
$149 month-to-month for the weekly compounded injection. Longer plans: $133/mo at three months, $99/mo at six; a one-time single month is $199.
$199 month-to-month, down from $229. Longer plans reach $133/mo at six months; a one-time single month is $279.
Ready to get started?
Plans and promotions change often — check Nirwana Health's current pricing and active discounts before you decide.
What we like
- Offers compounded semaglutide and tirzepatide as both weekly injections and oral tablets
- Transparent, published pricing with month-to-month, quarterly, and 6-month plans and no membership fee
- Multi-month plans cut the per-month cost sharply (semaglutide as low as $99/mo, tirzepatide as low as $133/mo)
- Advertises a $50-off code (LOOSE50) and covers weight loss plus hair, sexual-wellness, and longevity care
- Also lists a retatrutide option and custom dosing plans for higher needs
Watch-outs
- Prescribing medical group and compounding pharmacy are not named on the site
- States of operation are not published; confirm eligibility during intake
- Says it is 'LegitScript certified' but no verifiable seal is shown, so the claim is unconfirmed
- Compounded semaglutide and tirzepatide are not FDA-approved finished products
Is Nirwana Health worth it?
Nirwana Health's whole pitch comes down to this: oral or injectable compounded GLP-1 with cheaper multi-month plans. It runs $149/month at every dose — toward the affordable end of the category, so cost isn't the reason to look elsewhere. Its standout is a needle-free oral option, which very few providers offer.
Nirwana Health takes $50 off your first order.
How much Nirwana Health actually costs
Compounded semaglutide runs $149/month and compounded tirzepatide runs $199/month.
That puts Nirwana Health below the roughly $179 median across the GLP-1 providers we track (each one's cheapest ongoing monthly price) — a real cost advantage.
Gala (about $149/month) is one of the closest alternatives to weigh Nirwana Health against.
Medications: what Nirwana Health prescribes
Nirwana Health prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the pair backed by the largest published weight-loss trials. Rather than brand-name pens, you get a compounded formulation from a licensed pharmacy — the reason the monthly cost is lower. Just know compounded drugs aren't FDA-approved as finished products, the standard caveat in this market.
Nirwana Health's needle-free oral option is a real draw if you've been avoiding a GLP-1 because of injections. Just set expectations on the science: oral and buccal delivery of these peptides is far less studied than the injectable versions the trials used. Treat it as a convenience option, not a proven equal to the shot.
Who Nirwana Health is best for — and who should skip it
A good fit if you…
- are focused on the lowest ongoing monthly cost — $149/month is below the roughly $179 median we track across the category (from each provider's cheapest ongoing monthly price).
- are needle-averse and want a non-injectable option, since the oral route skips the weekly injection most GLP-1 programs require.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen instead of a compounded formulation — that's not what this provider fills.
- need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.
Trust, safety, and medical oversight
We found no FDA warning letter on file for it, though a clean record isn't the same as an endorsement — read the rest of this review for the full picture. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
Nirwana Health earns its place on the shortlist mainly on price: at $149/month it's one of the more affordable ways to stay on a GLP-1, without obvious corners cut on access or oversight.
The Bottom Line
Price is where Nirwana Health scores best in our breakdown.
Ready to start with Nirwana Health?
Starting at $149/month. See current pricing and start your free consultation.
Nirwana Health might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
- If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider altRX.
- If the lowest possible monthly price is your top priority, consider Collective (from $59/mo).
- If you want built-in coaching and behavior-change support, consider MEDVi.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Nirwana Health review:
Sources & methodology — as of October 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Nirwana Health's current pricing
Plans start at $149/month. Start your free consultation to check eligibility and today's price.